Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.
Evidence for a two-stage disability progression in multiple sclerosis.
Uses of complementary and alternative medicine in multiple sclerosis.
Color-Code Agreement Among Stratus, Cirrus, and Spectralis Optical Coherence Tomography in Relapsing-Remitting Multiple Sclerosis With and Without Prior Optic Neuritis.
Cystoid macular oedema after fingolimod treatment in multiple sclerosis.
Origin and evolution of deep brain stimulation.
Bayesian inferences for beta semiparametric-mixed models to analyze longitudinal neuroimaging data.
Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.
T-cell trafficking in the central nervous system.
Natalizumab Therapy for Multiple Sclerosis.
Multiple sclerosis: On the TRAIL of IFN-β response.
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.
The Communicative Participation Item Bank (CPIB): Item bank calibration and development of a disorder-generic short form.
Viruses and Multiple Sclerosis.
Longitudinal study of alexithymia and multiple sclerosis.
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
Validation of a new quality of life scale related to multiple sclerosis and relapses.
[2011: What's new in dysimmune neuropathies.]
Cine cerebrospinal fluid imaging in multiple sclerosis.
Review series on immune responses in neurodegenerative diseases: Oligodendrocyte-microglia cross-talk in the CNS.
[Recurring neuromyelitis without optic neuritis: a case report].
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies.
Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.
Epitope-specific CD8+ T cells play a differential pathogenic role in the development of a viral disease model for multiple sclerosis.
C-ANCA positive necrotising scleritis and multiple sclerosis compatible with ocular Wegener: treatment with rituximab.

Pages